Related Experiment Video
Updated: Jun 18, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Polyphyletic emergence of linezolid-resistant staphylococci in the United States
Agnes Wong1, Shilpa P Reddy, Davida S Smyth
1Department of Microbiology and Immunology, New York Medical College, Valhalla, NY, USA.
Abstract:
Since the year 2000, linezolid has been used in the United States to treat infections caused by antimicrobial-resistant Gram-positive cocci. At present, linezolid-resistant (Linr) Staphylococcus aureus and Staphylococcus epidermidis strains are rare and the diversity of their genetic backgrounds is unknown. We performed sequence-based strain typing and resistance gene characterization of 46 Linr isolates that were collected from local and national sources between the years 2004 and 2007. Resistance was found to occur in at least three clonal complexes (CCs; lineages) of S. aureus and in at least four subclusters of a predominant, phylogenetically unstable CC of S. epidermidis. New candidate resistance mutations in 23S rRNA and the L4 riboprotein were identified among the S. epidermidis isolates. These findings suggest that linezolid resistance has emerged independently in multiple clones of S. aureus and with a variety of ribosomal mutations in multiple clones of S. epidermidis.
Insights
Linezolid resistance in Staphylococcus aureus and epidermidis is rare but emerging across multiple genetic lineages. New ribosomal mutations were identified in Staphylococcus epidermidis, suggesting independent evolution of linezolid resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Linezolid is a crucial antibiotic for treating resistant Gram-positive cocci infections.
- Linezolid-resistant (Linr) Staphylococcus aureus and Staphylococcus epidermidis are currently rare.
- The genetic diversity and origins of Linr strains remain largely unknown.
Purpose of the Study:
- To characterize the genetic backgrounds of Linr Staphylococcus aureus and Staphylococcus epidermidis.
- To identify resistance mechanisms and genetic lineages associated with linezolid resistance.
Main Methods:
- Sequence-based strain typing was employed.
- Resistance gene characterization was performed.
- 46 Linr isolates collected between 2004-2007 were analyzed.
Main Results:
- Linezolid resistance was observed in at least three clonal complexes of Staphylococcus aureus.
- Resistance was found in at least four subclusters of a predominant Staphylococcus epidermidis clonal complex.
- Novel candidate mutations in 23S rRNA and L4 riboprotein were identified in Staphylococcus epidermidis.
Conclusions:
- Linezolid resistance has emerged independently in multiple clones of Staphylococcus aureus.
- Multiple clones of Staphylococcus epidermidis have independently developed linezolid resistance through various ribosomal mutations.
- Understanding these genetic underpinnings is vital for monitoring and combating antimicrobial resistance.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Investigation of Disease Outbreaks
Antimicrobial Effectiveness
Staphylococcal Skin Infections
